CHO cells are the preferred host for the production of complex pharmaceutical proteins in the biopharmaceutical industry, and genome engineering of CHO cells would benefit product yield and stability. Here, we demonstrated the efficacy of a Dnmt3a-deficient CHO cell line created by CRISPR/Cas9 genome editing technology through gene disruptions in Dnmt3a, which encode the proteins involved in DNA methyltransferases. The transgenes, which were driven by the 2 commonly used CMV and EF1a promoters, were evaluated for their expression level and stability. Under the CMV promoter, the Dnmt3a-deficent cell line with a high transgene expression displayed a low methylation rate in the promoter region and global DNA.
attachment regions, 10, 11 ubiquitous chromatin opening elements [12] [13] [14] and insulators. 15 Transgene silencing is also associated with the methylated cytosine on the CpG sites of promoters in recombinant protein-producing CHO cells. 16 Yang et al 17 found an increase in the methylation of the human cytomegalovirus major immediate-early (hCMV-MIE) promoter, which controls the monoclonal antibody expression in unstable cell lines with low productivity. Moreover, they discovered that the lost productivity of specific mAb can be partially restored by treating these cells with 5-Aza-2-deoxycytidine (which is a DNA methylation inhibitor). These findings suggested that epigenetic factors, such as DNA methylation, possibly contribute to the loss of productivity and play important roles in regulating gene expression. 18 Therefore, elucidating the effects of DNA methylation and its mechanism on transgene expression would benefit the development of recombinant CHO cell lines that produce both high and stable production.
Previous studies on the effect of DNA methylation on the transgene expression in CHO cells have mainly focused on promoter modification, such as mutating the cytosine within promoters, 19 using CpG-free 20 or synthetic promoters 21 and inserting core CpG island elements into promoters. 22 Nonetheless, although a promoter without CpG dinucleotides could mitigate early gene silencing, it still cannot improve the long-term expression stability in transfected CHO cells. 20 DNA methylation is catalysed by DNA methyltransferases, including those which establish methylation (Dnmt3a and Dnmt3b) 23 and maintain methylation (Dnmt1). 18 In particular, Dnmt3a and Dnmt3b mediate epigenetic silencing through histone modification and subsequently DNA methylation. 24 As inhibitors, quinolone analogues are potent against human Dnmt3a, which can induce the re-expression of a reporter gene controlled by a methylated CMV promoter in leukaemia KG-1 cells. 25 Thus, we proposed that modifying the CHO cell line through the gene knockout of DNA methyltransferase would improve the expression stability of permanently transfected CHO cells during long-term cultivation. To validate this hypothesis, we knocked out the Dnmt3a gene through CRISPR/Cas9 genome editing technology to establish a Dnmt3a-deficient CHO cell line and investigated the transgene expression level and stability in the deficient cells.
| MATERIALS AND METHODS

| sgRNA target design for Dnmt3a KO and plasmid construction
A DNA fragment 3a3 + 4 of Dnmt3a (NW_003613640.1) containing exon1 was amplified by polymerase chain reaction (PCR) from the genomic DNA of CHO-K1 cells using primers (Table 1) . Two pairs of sgRNAs used for targeting the exon1 of Dnmt3a (Table 1) were subjected to gradient and limiting dilution to select the single clones of Dnmt3a KO cells. These single putative clones were identified through PCR amplification using the sequencing primers ( Table 1 ). The expected PCR products were cloned into the pMD18-T vector (TaKaRa) and sequenced for further confirmation.
Quantitative detection in vitro was performed using DNMT3A
ELISA kit (RenJie, Shanghai, China) to determine the concentrations of Dnmt3A in the Dnmt3a KO CHO-K1 cells. After the stop solution was added, the blue colour changed to yellow, and the intensity was measured using a spectrophotometer at 450 nm. The calibration standards were also assayed. 
| Construction of the expression vectors and transient transfection
The pWTY-CMV and pWTY-EF1a vectors, which contained either the CMV (589 bp) or the EF1a (1335 bp) promoters, were constructed by cloning eGFP as a report gene from pEGFP-C1 (Clontech, USA) into the pIRES-neo vector (Clontech). 26 The sequences of the elements were synthesized and sequenced by General Biosys- 
| Analysis of cell characteristics
Cell viability was measured using Cell Counting Kit-8 (Dojindo, Kamimashiki-gun, Kumamoto, Japan) in accordance with the manufac- analysis was performed using the Guava EasyCyte 6-2L system (Merckmillipore, USA), and data were analysed by Guava InCyte
The cell doubling time (t D ) was determined to evaluate the growth characteristics of the normal CHO-K1 cells, the Dnmt3a-deficient cells and the cells stably transfected with CMV or EF1a.
Briefly, the cells were seeded into 6-well plates at 1 9 10 5 cells/mL and allowed to grow for 2, 4, 6, 10, 24 and 48 hours at 37°C under 5% CO 2 prior to cell counting using a haemocytometer measurement tool and trypan blue staining assay. The t D value was determined by the formula t D = (t 2 Àt 1 ) 9 (log(2)/log(C 2 /C 1 )), where C 2 and C 1 are the cell concentrations at times t 2 and t 1 , respectively, under a constant growth rate.
| Long-term stability analysis for stably transfected cells
Stably transfected cell polycolonies were selected by adding Geneticin A standard curve was used to quantify the absolute amount of methylated DNA (the percentage of 5-mC) in the total genomic DNA. Each sample was assessed in duplicate.
| Promoter methylation patterns by MALDI-TOF mass array
Quantitative methylation changes in CMV and EF1a in the transfected cells were compared using high-throughput mass spectrometry on the matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass array. Briefly, genomic DNA was extracted from CHO cell polycolonies stably transfected with the vectors containing CMV or EF1a at the start and at 50 passages of stability testing. Isolated genomic DNA was treated with bisulphite using the EZ DNA Methylation Kit (Zymo Research, USA). We designed primers for CMV and EF1a to cover the regions with the main CpG sites (Table 1) . For PCR amplification, a T7-promoter tag was added to the reverse primer, and a 10-mer tag sequence was added to the forward primer to balance PCR primer length. The following PCR programs were used to amplify the bisulphite-treated genomic DNA ; SEQUENOM). Mass spectra were obtained using
MassARRAY Compact MALDI-TOF (SEQUENOM), and methylation ratios of the spectra were generated using EpiTYPER software v1.0 (SEQUENOM).
| Statistical analysis
The data were expressed as means AE standard deviation. All statistical analyses were performed on the SPSS 18.0 (SPSS, Inc., Chicago, IL, USA). One-way ANOVA was used to compare multiple groups.
Paired-sample Student's t test was used for statistical analysis when only 2 groups were tested. P < .05 was considered statistically significant. All experiments were performed at least thrice, and all samples were tested in triplicate.
| RESULTS
| Dnmt3a KO by CRISPR/Cas9 genome editing
The CRISPR/Cas9 system was facilitated to generate Dnmt3a KO in 
| Analysis of cells characteristics
The detection of cell proliferation and apoptosis indicated that Table 2 . Results demonstrated that Dnmt3a deletion did not significantly affect the doubling times Figure 3B ). Basing on the identification results, we selected one Dnmt3a-deficient cell line (3a-30) that had undergone dual allelic inactivation for further functional studies.
| Transient expression and transfection efficiency
Expression vectors driven by CMV or EF1a were transfected into 2 CHO cell lines, namely 3a-30 and normal CHO-K1 cells. After being transfected for 48 hours, the transfected cells were collected to observe the transfection efficiency under a fluorescence microscope.
As shown in Figure 4A , no obvious differences were observed in the transfection efficiency of all of the transfected cells. Rates of positive clones in the cells transfected with CMV were slightly higher than those in the cells transfected with EF1a ( Figure 4B ). These results indicated that the Dnmt3a KO in CHO-K1 cells had no effect on transient expression and transfection efficiency. Rates of DNA methylation in the analysed 25 CpG sites of EF1a at the start and at high passage (P50) were low and had no differences in the transfected 3a-30 and normal CHO cell lines ( Figure 6B ).
| Effects of Dnmt3a KO on the recombinant expression in the stably transfected cells
| DISCUSSION
Previous reports have shown that the DNA hypermethylation in the promoter region can cause instability in stable recombinant CHO cell lines. 16, 17 Previous report showed that Dnmt3a knockout CHO cell lines were constructed using the CRISPR-Cas9 system without homologous regions. 28 Thus, we established a DNA methyltransferase The CRISPR/Cas9 genome editing technology has been extensively applied for modifying a single gene into a genome-wide regulation of genes through the rapid, easy and efficient engineering of mammalian genomes. 29 This editing system is a highly efficient tool The hCMV-MIE provides high levels of transgene expression;
however, its loss of productivity has been reported with prolonged cultivation time. 37, 38 hCMV-MIE is prone to transgene silencing, which is associated with DNA methylation. 16, 17, 37, 39 Moreover, recombinant CHO cell lines with EF1a exhibited loss of productivity during long-term culture. 26, 40 Therefore, to monitor the effects of are critical sites that prevent or inhibit transcription. 41 Compared with CMV, EF1a displayed decreased rates of DNA methylation, which presented no significant differences between the 3a-30 and normal control CHO cells at the start and at 50 passages, suggesting that the density of methylation in a given region determines whether or not transcription would be prevented. 42 The possible reason is that the effect of CpG methylation on gene expression is context dependent 43 ;
that is, the degree of CpG methylation change, the density or the genomic location of CpG, methyl-CpG "readers" and TF binding are 
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